Universal vaccination of healthy children against influenza: A role for the cold-adapted intranasal influenza vaccine

被引:11
作者
Jacobson R.M. [1 ]
Poland G.A. [2 ]
机构
[1] Department of Pediatric and Adolescent Medicine, Vaccine Research Group, Mayo Clinic, Rochester, MN
[2] Department of Internal Medicine, Vaccine Research Group, Mayo Clinic, Rochester, MN
关键词
Influenza; Kawasaki Disease; Influenza Vaccine; Influenza Vaccination; Universal Vaccination;
D O I
10.2165/00128072-200204010-00007
中图分类号
学科分类号
摘要
The incidence of influenza in children well exceeds that of the elderly and has been identified as the basis for 20% of doctor visits for children during the winter. The disease results in over 100 hospitalizations per 100 000 person-months in children <2 years of age. Furthermore, children serve as the major vector in the community; thus, influenza in children results in significant costs to society. Although efficacious, the current intramuscular, inactivated influenza vaccine is infrequently used in children, and is currently targeted only at children at high risk and those who are household members of such individuals. Experts believe that vaccinating only high risk individuals has little impact on the cycle of annual epidemics, but that universal vaccination of children may very well have a substantial impact. Experimental data support this. A recently published cost-benefit analysis indicated that routine, school-aged vaccination through individual visits to a clinician would save $US4 per child vaccinated. A group program such as a school-based one would save $US35. One obstacle to universal vaccination includes the real and perceived resistance to the addition of yet another annual injection to the already crowded schedule of routine childhood immunizations. Nearing licensure is an intranasal, live attenuated, cold-adapted intranasal influenza vaccine. Cold-adaptation prevents replication in the lower respiratory tract. Trials have demonstrated immunogenicity, safety, and tolerability in adults as well as children. Placebo-controlled trials have shown efficacy rates of 83 to 94%. This novel vaccine addresses obstacles to universal childhood immunization and would permit a program of routine use that would dramatically reduce transmission and stem epidemics of influenza.
引用
收藏
页码:65 / 71
页数:6
相关论文
共 58 条
  • [1] Longini Jr. I.M., Koopman J.S., Haber M., Et al., Statistical inference for infectious diseases: Risk-specific household and community transmission parameters, Am J Epidemiol, 128, 4, pp. 845-859, (1988)
  • [2] Monto A.S., Davenport F.M., Napier J.A., Et al., Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of school children, J Infect Dis, 122, 1, pp. 16-25, (1970)
  • [3] Reichert T.A., Sugaya N., Fedson D.S., Et al., The Japanese experience with vaccinating school children against influenza, N Engl J Med, 344, 12, pp. 889-896, (2001)
  • [4] Langmuir A.D., Henderson D.A., Serfling R.E., The epidemiological basis for the control of influenza, Am J Public Health, 54, pp. 563-571, (1964)
  • [5] Elveback L.R., Fox J.P., Ackerman E., Et al., An influenza simulation model for immunization studies, Am J Epidemiol, 103, pp. 152-165, (1976)
  • [6] Longini I.M., Ackerman E., Elveback L.R., An optimization model for influenza A epidemics, Math Biosci, 38, pp. 141-157, (1978)
  • [7] Monto A.S., Koopman J.S., Longini Jr. I.M., Tecumseh study of illness, XIII, influenza infection and disease, 1976-1981, Am J Epidemiol, 121, 6, pp. 811-822, (1985)
  • [8] Fox J.P., Hall C.E., Cooney M.K., Et al., Influenzavirus infections in Seattle families. 1975-1979. I: Study design, methods and the occurrence of infections by time and age, Am J Epidemiol, 116, 2, pp. 212-227, (1982)
  • [9] Carrat F., Flahault A., Boussard E., Et al., Surveillance of influenza-like illness in France: The example of the 1995/1996 epidemic, J Epidemiol Comm Health, 52, 1 SUPPL., (1998)
  • [10] Long C.E., Hall C.B., Cunningham C.K., Et al., Influenza surveillance in community-dwelling elderly compared with children, Arch Fam Med, 6, 5, pp. 459-465, (1997)